Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Financial Results
Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.
UK firm Dechra Pharmaceuticals is predicting around 18% growth during its fiscal first half of 2019.
Czech Republic-based Bioveta maintained its recent double-digit sales growth into fiscal 2018.
Elanco has predicted sales growth next year, which could be the first time its annual revenues increase since 2015.
UK firm ECO Animal Health posted a 9% increase in sales during the six months ended September 30, 2018.
US distributor Patterson Companies' animal health business continued to maintain a healthy financial display into the second quarter of fiscal 2019.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.